Civik Thomas 4
4 · Pyxis Oncology, Inc. · Filed Nov 19, 2021
Insider Transaction Report
Form 4
Civik Thomas
DirectorInterim CEO
Transactions
- Purchase
Common Stock
2021-11-18$12.74/sh+15,700$200,018→ 15,700 total(indirect: By Trust)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.47 to $13.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F2]These shares are held directly by the Civik Family Trust, a revocable trust for which the Reporting Person and his spouse are the grantors.